Gapping down
In reaction to earnings/guidance:
- MIMO -3.8%, ACI -3.7%, KMX -2.7%, GOL -1.4%
Other news:
- MYOV -20.8% (Myovant Sciences and and Pfizer (PFE) provide update on sNDA for MYFEMBREE)
- WULF -9.1% (stock offering)
- RPTX -4.9% (presents updated data from ongoing Phase 1/2 TRESR study)
- VMEO -3.3% (reports monthly metrics for March)
- ENSG -3.2% (receives new $600 million credit facility)
- LFLY -0.9% (stock offering)
- BEN -0.8% (reports March AUM)
Analyst comments:
- ENJY -4.7% (downgraded to Market Perform from Outperform at Telsey Advisory Group)
- CHGG -3.7% (downgraded to Sector Weight from Overweight at KeyBanc Capital Markets)
- HPE -3.4% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- DAN -2.8% (downgraded to Equal Weight from Overweight at Wells Fargo)
- CSCO -2.5% (downgraded to Sell from Neutral at Citigroup)
- FHI -2.3% (downgraded to Sell from Neutral at Citigroup)
- FFIV -1.6% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- DNUT -1.5% (downgraded to Neutral from Buy at Citigroup)
- ABC -1.2% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- FISV -1.1% (downgraded to Market Perform from Outperform at Cowen)